NCT00454103
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
- Locations
-
- Würzburg, Germany
Clinical trial condition
Adrenal Cortex Diseases
Explore clinical trials studying Adrenal Cortex Diseases. Study availability and eligibility vary by location and protocol.
96 public trials
29 recruiting studies
Adrenal Cortex Diseases trial results
NCT00768365
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +6 more
- Locations
-
- Istanbul University Istanbul, Capa, Turkey (Türkiye)
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00264433
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +40 more
- Locations
-
- Florida Cancer Specialist Fort Myers, Florida, United States
- Lineberger Comprensive Cancer Center Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Centre Durham, North Carolina, United States
- Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States
Active, Not Recruiting
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
NCT03333616
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
- Locations
-
- University of California, San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, Not Recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
NCT00457587
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +13 more
- Locations
-
- Dept. of Medicine I, University of Wuerzburg Würzburg, Germany
Active, Not Recruiting
Evaluation of Side Effects of Mitotane
NCT00568139
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- University Hospital Würzburg, Germany